X-Genix
Precision Molecule Editing,
Accelerating drug discovery………
We are X-Genix. Together we are using our world-leading technology in ML, engineering biology and enzymology to directly and precisely access chemical space around pharmaceutically relevant molecules and biomolecules from just over 100Da to >>5KDa, surpassing what was previously imaginable.
About Us
X-Genix:
is a disruptive biotech start-up
Enabling, for the first time, precision molecule editing:
giving direct access to otherwise hard to reach chemical space through leveraging the power of enzymes, using its AI informed EngBio platform.
We are building the future of molecule making and developing new pipelines of molecules for targeted therapeutic delivery.
X-Genix: pioneering the future of molecule making and editing
We are pioneers of precision molecule editing, enabling for the first time, one step, selective access to diverse and unchartered space around simple to functionally elaborate small molecules and biomolecules.
The Vision: fill pharma pipelines by enabling direct access to best to make pharmaceutical space.
We are harnessing this technology to develop series of molecules for targeted therapeutics.
Funding and Investment
Investing in X-Genix:
We will be opening our first seed raise in 2026
X-Genix has benefitted from ~£3M of translational, non-dilutive, funding from UKRI, ERC, Scottish Enterprise and IBIOIC, and arises from a multi award winning lab that has secured over £15M of funding
Partnering
Partnering with X-Genix
At X-Genix, we believe that transformational breakthroughs start with strong collaboration. By joining forces with visionary partners, we unleash bold ideas. Together, we can shape the next frontier of innovative drug discovery.
Our Technology
Our science is founded on over 25 years of multi award winning academic innovation
pioneering breakthroughs in blending engineered biology with synthetic chemistry to access best to make pharmaceutical space.
Use of our extensive suite of editing enzymes enables early, mid and late stage vectorisation and functionalisation of small, medium through to very large and sophisticated molecules.